Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Current management of differentiated thyroid carcinoma.

Gelsy Arianna Lupoli1, Francesco Fonderico, Sara Colarusso

  • 1Department of Molecular and Clinical Endocrinology and Oncology, Faculty of Medicine and Surgery, Federico II University, Naples, Italy.

Medical Science Monitor : International Medical Journal of Experimental and Clinical Research
|December 2, 2005
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Virus-induced sacroiliitis: parvovirus B19 expands the spectrum of spondyloarthritis-like phenotypes.

Clinical and experimental rheumatology·2026
Same author

The at-risk-to-early continuum of enteropathic spondyloarthritis.

The Lancet. Rheumatology·2026
Same author

TOGETHER-PsA and the case for precision phenotyping in psoriatic arthritis: comment on the article by Merola et al.

Arthritis & rheumatology (Hoboken, N.J.)·2026
Same author

Spuriously elevated estradiol due to immunoassay interference in the workup of a suspected ovarian tumor: Diagnostic pitfalls and laboratory workflow recommendations.

Clinical biochemistry·2026
Same author

Application of machine learning techniques to explore the occurrence of macrophage activation syndrome in Still's disease: results from the GIRRCS AOSD Study Group and the AIDA Network Still's Disease Registry.

Frontiers in immunology·2026
Same author

Peritonitis Due to Streptococcus uberis in a Patient on Automated Peritoneal Dialysis: A Case Report and Literature Review.

Cureus·2025

Differentiated thyroid cancers (DTC) management involves surgery and radioactive iodine therapy. Recombinant human TSH (rh-TSH) may eliminate the need for radioactive iodine scans in follow-up evaluations.

Area of Science:

  • Endocrinology
  • Oncology
  • Nuclear Medicine

Background:

  • Differentiated thyroid cancers (papillary and follicular) are the most common thyroid carcinomas with a good prognosis.
  • Fine-needle aspiration (FNA) cytology is the initial diagnostic step for thyroid nodules.
  • Standard treatment involves surgery (near-total or total thyroidectomy) followed by radioactive iodine (131I) ablation.

Purpose of the Study:

  • To evaluate the role of recombinant human TSH (rh-TSH) in the follow-up of differentiated thyroid cancer patients.
  • To explore the potential of rh-TSH-stimulated thyroglobulin (Tg) levels as a sole diagnostic marker, avoiding radioactive iodine scans.

Main Methods:

  • Patients with differentiated thyroid cancer undergo 131I ablation therapy and total body scans (TBS).

Related Experiment Videos

  • Follow-up includes L-tiroxine therapy to suppress TSH and periodic evaluation of TSH and thyroglobulin (Tg).
  • An alternative follow-up method involves administering rh-TSH to stimulate Tg levels, followed by 131I administration and TBS.

    • Main Results:

    • The standard follow-up requires TSH suppression with L-tiroxine and periodic Tg evaluation, often necessitating thyroxine withdrawal, leading to hypothyroidism.
    • Administration of rh-TSH allows for 131I administration and TBS 48-72 hours later, without inducing hypothyroidism.
    • Emerging research suggests rh-TSH-stimulated Tg levels alone may suffice to distinguish between persistent disease and disease-free status.

    Conclusions:

    • Recombinant human TSH (rh-TSH) offers a promising alternative for differentiated thyroid cancer follow-up.
    • rh-TSH-stimulated thyroglobulin (Tg) levels may potentially replace radioactive iodine total body scans (TBS) in disease monitoring.
    • This approach could simplify follow-up protocols and improve patient compliance by avoiding induced hypothyroidism.